內網

檢測到您當前使用瀏覽器版本過於老舊,會導致無法正常瀏覽網站;請您使用電腦裏的其他瀏覽器如:360、QQ、搜狗瀏覽器的極速模式瀏覽,或者使用穀歌、火狐等瀏覽器。

下載Firefox

The role of cell of origin and cancer stem cells in glioblastoma

日期: 2019-08-16
明升体育學術報告
題目:The role of cell of origin and cancer stem cells in glioblastoma
主講人:Luis F. Parada, PhD
Director
Brain Tumor Center
Memorial Sloan Kettering Cancer Center
時間:2019年8月28日(星期三)10:00-11:30
地點:金光生命科學大樓鄧祐才報告廳
主持人:吳虹教授
摘要:
The adult mammalian brain is composed of a diversity of cell types. Using genetically engineered mouse models, we have addressed whether there exists equivalent tumorigenic potential among the diverse cell types. Our results indicate that while adult neural stem and progenitor cells harboring tumor suppressor mutations readily give rise to GBM, more differentiated neurons and glia harboring the same mutations do not create tumors. We have extended these studies to examine whether different cell lineages can give rise to tumors and find that both SVZ derived as well as oligodendrocytic lineage progenitor cells harboring identical mutations can produce GBM. However, the GBMs arising from the two different lineages exhibit subtle but distinct tumor phenotypes and harbor transcriptomes that reflect their specific cells of origin. Evidence that these two GBM subtypes are present in the human GBM data-­‐base suggest that GBM may be stratified based on cell of origin and may provide a functional premise for therapeutic evaluation. Finally, we confirm that hierarchical tumor growth originally seen in mouse models is also present in human GBM and that targeting of quiescent cancer stem cells will be essential in curing this disease.
歡迎各位老師同學積極參加!